The SpaceX Lockup Expiration Isn’t About Price, It’s About Signal.

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

SpaceX's honeymoon as a public company lasted almost exactly seven weeks. The company IPO'd on June 12, and by Tuesday's first-ever earnings report as a public entity, it had already shed more than $500 billion in market capitalization. The report itself wasn't the problem — SpaceX beat revenue expectations. What sent the stock down 13.6% was a single line buried in the numbers: capital expenditures jumped sixfold to $18.4 billion in one quarter, the bulk of it tied to AI infrastructure spending.

That would be a rough week under any circumstances. But today, the story gets more dangerous. Roughly $101 billion worth of SpaceX shares become eligible for trading for the first time, as the company's post-IPO lockup period expires. A stock already reeling from a spending scare is now facing a fresh supply of shares that early investors, employees, and insiders have been legally barred from selling since June — and can sell starting today.

This is the part of the story that hasn't happened yet. The earnings reaction is done. The SpaceX lockup expiration is not.

What The Market Already Knows

The bear case going into today is straightforward and already priced...

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

Related Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

CoreWeave Insider Selling: Why CEO Paused After $794 Million

CoreWeave (NASDAQ: CRWV) has given investors an unusual question...

Nvidia Jensen Scandal: Can Nvidia Survive Without Huang?

What happens when the man who helped build the...

Micron Stock Forecast: Could AI Fuel 148% Upside?

Micron Technology (NASDAQ: MU) has become one of Wall...
spot_img

Related Articles

Popular Categories

spot_imgspot_img